Frequently Asked Questions
The market is segmented based on Global Arteriovenous Malformations (AVMs) Market, By Type (True Arteriovenous Malformation, Occult or Cryptic, Cavernous Malformations, Venous Malformation, Hemangioma, Dural Fistula, Others), Stages (Stage I (Quiescence), Stage II (Expansion), Stage III (Destruction), Stage IV (Decompensation), Others), Treatment (Diagnosis, Medication, Surgery, Others), End-Users (Hospitals, Specialty Clinics, Home Healthcare, Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2030.
.
The Global Arteriovenous Malformations Avms Market size was valued at USD 2758.27 USD Million in 2022.
The Global Arteriovenous Malformations Avms Market is projected to grow at a CAGR of 6.1% during the forecast period of 2023 to 2030.
The major players operating in the market include Electrical Geodesics , Siemens Healthcare, Masimo Corporation, Esaote, Shimadzu Corporation, Toshiba Medical Systems Corporation, Carestream Health, Philips Healthcare, Pfizer , Eli Lilly and Company, Novartis AG, F. Hoffmann La Roche Ltd, Eisai Co.,.
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa.
